Published May 8, 2021, 2:59 PM
The Task Group on Vaccine Evaluation and Selection (TG-VES) is closely coordinating with 31 vaccine manufacturers and developers for supply of coronavirus disease (COVID-19) vaccines in the country.
A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. (Xinhua/Zhang Yuwei / MANILA BULLETIN)
This was disclosed by Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara, who heads the task group, which provides recommendations on which vaccines will be considered for negotiation and procurement.
“Dahil sa limitado na kakayahan ng Pilipinas na magsagawa ng vaccine development, ang pamahalaan sa pamamagitan po ng DOST ay nakikipag-ugnayan sa ilang bilateral partners para sa vaccine development at clinical trials (Due to the limited capacity of the Philippines to conduct vaccine development, the government through DOST is coordinating with sev
3 more Chinese vaccine developers apply for COVID-19 vaccine trials in PH mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Published May 5, 2021, 11:02 AM
The chief of the Task Group on Vaccine Evaluation and Selection (TG-VES) is not surprised by the decision of the Food and Drug Administration (FDA) to issue an emergency use authorization (EUA) to the coronavirus disease (COVID-19) vaccine developed by United States-drug company Moderna.
Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara
“This is expected since Moderna received EUA in other countries with stringent regulatory authorities (SRAs),” Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara said in a VIber message to the Manila Bulletin on Wednesday, May 5.
DOST Secretary Fortunato “Boy” T. de la Peña also cheered at the FDA’s EUA grant to the Moderna’s coronavirus jab.
Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara (Manila Bulletin File Photo)
Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara, who leads the TG-VES, said more vaccine manufacturers were expected to file their EUA application before the Food and Drug Administration (FDA).
“Two or three more,” she told the Manila Bulletin in a Viber message when asked on the number of vaccine developers that will apply for EUA of their COVID-19 vaccines.
She said while, they were expecting more applicants, “we might not have any EUA approvals this month.”
Guevara noted that it takes longer than one week for the FDA to process EUA applications.
DOST
DOST Secretary Fortunato “Boy” T. de la Peña and Undersecretary Rowena Cristina Guevara, chair of the Task Group on Vaccine Evaluation and Selection (TG-VES), cited Moderna’s filing of its EUA application before the Food and Drug Administration (FDA) on Monday, April 26.
“The more brands granted EUA by our FDA means we have more choices and bigger chances for vaccine availability,” de la Peña told the Manila Bulletin in a Viber message.
FDA Director General Eric Domingo announced that Moderna has filed its EUA application before the regulatory body on Monday, April 26.
“We have been expecting this for some time now,’ Guevara said.